344 related articles for article (PubMed ID: 19564338)
1. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
2. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity.
Cissé MA; Sunyach C; Lefranc-Jullien S; Postina R; Vincent B; Checler F
J Biol Chem; 2005 Dec; 280(49):40624-31. PubMed ID: 16236709
[TBL] [Abstract][Full Text] [Related]
3. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
4. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
McDonald AJ; Dibble JP; Evans EG; Millhauser GL
J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
[TBL] [Abstract][Full Text] [Related]
5. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
6. Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.
Chen C; Lv Y; Zhang BY; Zhang J; Shi Q; Wang J; Tian C; Gao C; Xiao K; Ren K; Zhou W; Dong XP
Mol Neurobiol; 2014 Dec; 50(3):875-87. PubMed ID: 24771043
[TBL] [Abstract][Full Text] [Related]
7. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
8. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
9. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.
Herzog C; Haun RS; Ludwig A; Shah SV; Kaushal GP
J Biol Chem; 2014 May; 289(19):13308-22. PubMed ID: 24662289
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
11. Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9.
Franzke CW; Bruckner-Tuderman L; Blobel CP
J Biol Chem; 2009 Aug; 284(35):23386-96. PubMed ID: 19574220
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase.
Cissé MA; Gandreuil C; Hernandez JF; Martinez J; Checler F; Vincent B
Biochem Biophys Res Commun; 2006 Aug; 347(1):254-60. PubMed ID: 16806063
[TBL] [Abstract][Full Text] [Related]
13. The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.
Cissé M; Duplan E; Guillot-Sestier MV; Rumigny J; Bauer C; Pagès G; Orzechowski HD; Slack BE; Checler F; Vincent B
J Biol Chem; 2011 Aug; 286(33):29192-29206. PubMed ID: 21586567
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.
Prox J; Willenbrock M; Weber S; Lehmann T; Schmidt-Arras D; Schwanbeck R; Saftig P; Schwake M
Cell Mol Life Sci; 2012 Sep; 69(17):2919-32. PubMed ID: 22446748
[TBL] [Abstract][Full Text] [Related]
15. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
[TBL] [Abstract][Full Text] [Related]
16. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
17. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.
Gardiner EE; Karunakaran D; Shen Y; Arthur JF; Andrews RK; Berndt MC
J Thromb Haemost; 2007 Jul; 5(7):1530-7. PubMed ID: 17445093
[TBL] [Abstract][Full Text] [Related]
18. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
Saftig P; Reiss K
Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
[TBL] [Abstract][Full Text] [Related]
19. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
20. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
